Published in J Biol Chem on October 31, 1997
The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev (2007) 6.79
Regulation of intrarenal angiotensin II in hypertension. Hypertension (2002) 3.34
Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int (2002) 3.23
Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension. Hypertension (2003) 2.99
Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension (2001) 2.80
Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol (2012) 2.58
Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J Am Soc Nephrol (2011) 2.04
Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension (2008) 1.99
Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice. Am J Physiol Renal Physiol (2007) 1.87
Overexpression of mouse angiotensinogen in renal proximal tubule causes salt-sensitive hypertension in mice. Am J Hypertens (2012) 1.74
Intrarenal transfer of an intracellular fluorescent fusion of angiotensin II selectively in proximal tubules increases blood pressure in rats and mice. Am J Physiol Renal Physiol (2011) 1.59
Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases. Am J Hypertens (2006) 1.46
Redox control of renal function and hypertension. Antioxid Redox Signal (2008) 1.45
New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II. Peptides (2011) 1.32
Overexpression of angiotensinogen increases tubular apoptosis in diabetes. J Am Soc Nephrol (2007) 1.22
Intrarenal angiotensin II levels in normal and hypertensive states. J Renin Angiotensin Aldosterone Syst (2001) 1.18
Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study). J Hypertens (2010) 1.18
Collecting Duct Renin: A major player in Angiotensin II-dependent Hypertension. J Am Soc Hypertens (2010) 1.14
Renal proximal tubule angiotensin AT1A receptors regulate blood pressure. Am J Physiol Regul Integr Comp Physiol (2011) 1.12
Intrarenal angiotensin II and hypertension. Curr Hypertens Rep (2003) 1.10
Renal renin-angiotensin system. Contrib Nephrol (2004) 1.09
Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy. J Investig Med (2013) 1.09
Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease. Pflugers Arch (2012) 0.99
An androgen-inducible proximal tubule-specific Cre recombinase transgenic model. Am J Physiol Renal Physiol (2008) 0.92
Proximal tubule-dominant transfer of AT(1a) receptors induces blood pressure responses to intracellular angiotensin II in AT(1a) receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol (2013) 0.91
Hormone-specific regulation of the kidney androgen-regulated gene promoter in cultured mouse renal proximal-tubule cells. Biochem J (2002) 0.91
Contribution of a nuclear factor-kappaB binding site to human angiotensinogen promoter activity in renal proximal tubular cells. Hypertension (2011) 0.87
Proximal tubule angiotensinogen modulation of arterial pressure. Curr Opin Nephrol Hypertens (2013) 0.85
Divergent mechanism regulating fluid intake and metabolism by the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol (2011) 0.84
Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease. Int J Clin Med (2011) 0.84
Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice. Diabetes (2012) 0.83
Role of angiotensin AT(2) receptors in natriuresis: Intrarenal mechanisms and therapeutic potential. Clin Exp Pharmacol Physiol (2013) 0.83
Renin-angiotensin-aldosterone system-mediated redox effects in chronic kidney disease. Transl Res (2009) 0.83
Bcl-2-modifying factor induces renal proximal tubular cell apoptosis in diabetic mice. Diabetes (2011) 0.83
Possible role for nephron-derived angiotensinogen in angiotensin-II dependent hypertension. Physiol Rep (2016) 0.81
Angiotensin receptor-associated proteins: local modulators of the renin-angiotensin system. Pflugers Arch (2012) 0.80
Increased expression of p21WAF1/CIP1 in kidney proximal tubules mediates fibrosis. Am J Physiol Renal Physiol (2014) 0.80
Tubular overexpression of gremlin induces renal damage susceptibility in mice. PLoS One (2014) 0.80
HCaRG accelerates tubular repair after ischemic kidney injury. J Am Soc Nephrol (2011) 0.80
Urinary Angiotensinogen as a Novel Biomarker of Intrarenal Renin-Angiotensin System in Chronic Kidney Disease. Int Rev Thromb (2011) 0.80
UT-A urea transporter promoter, UT-Aalpha, targets principal cells of the renal inner medullary collecting duct. Am J Physiol Renal Physiol (2005) 0.79
Intratubular Renin-Angiotensin System in Hypertension. Curr Hypertens Rev (2006) 0.78
Salt-Sensitive Hypertension: Perspectives on Intrarenal Mechanisms. Curr Hypertens Rev (2015) 0.77
Transgenic mice and their impact on kidney research. Pflugers Arch (2008) 0.77
Identification and characterization of an androgen-responsive Kap promoter enhancer located in the intron II region of human angiotensinogen gene. J Steroid Biochem Mol Biol (2010) 0.76
Suppressing kidney angiotensinogen in blood pressure regulation. Physiol Rep (2016) 0.75
Overexpression of heterogeneous nuclear ribonucleoprotein F stimulates renal Ace-2 gene expression and prevents TGF-β1-induced kidney injury in a mouse model of diabetes. Diabetologia (2015) 0.75
Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli. Nucleic Acids Res (1984) 3.94
Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation (2000) 3.82
Antibiotic resistance mutations in ribosomal RNA genes of Escherichia coli. Methods Enzymol (1988) 3.60
Nucleotide sequence homology at 12 intron--exon junctions in the chick ovalbumin gene. Nature (1978) 3.30
Complete nucleotide sequence of the chicken chromosomal ovalbumin gene and its biological significance. Biochemistry (1981) 2.67
Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. Physiol Genomics (2001) 2.58
Ovomucoid intervening sequences specify functional domains and generate protein polymorphism. Cell (1980) 2.57
Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell (1999) 2.57
Nonsense codons in human beta-globin mRNA result in the production of mRNA degradation products. Mol Cell Biol (1992) 2.51
The chick ovomucoid gene contains at least six intervening sequences. Nature (1979) 2.01
Differential expression of angiotensin receptor 1A and 1B in mouse. Am J Physiol (1994) 1.91
RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int (2006) 1.88
Erythromycin resistance due to a mutation in a ribosomal RNA operon of Escherichia coli. Proc Natl Acad Sci U S A (1982) 1.73
The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circ Res (1998) 1.73
Critical roles of a cyclic AMP responsive element and an E-box in regulation of mouse renin gene expression. J Biol Chem (2001) 1.72
Sequence of three introns in the chick ovalbumin gene. Nature (1979) 1.69
Molecular cloning of ovomucoid gene sequences from partially purified ovomucoid messenger RNA. Biochemistry (1978) 1.67
Developmental changes in glucocorticoid receptor and 11beta-hydroxysteroid dehydrogenase oxidative and reductive activities in rat Leydig cells. Endocrinology (1997) 1.65
Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice. Physiol Genomics (1999) 1.60
Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest (2000) 1.59
Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest (1996) 1.59
Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am J Physiol (1998) 1.57
Testosterone: a major determinant of extragenital sexual dimorphism. Science (1981) 1.53
Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ Res (2001) 1.50
Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J Hypertens (1999) 1.42
The ovalbumin gene: structural sequences in native chicken DNA are not contiguous. Proc Natl Acad Sci U S A (1978) 1.42
Isolation and properties of a thermostable restriction endonuclease (ENDO R-Bst1503). J Bacteriol (1977) 1.37
Differential requirement for SLP-76 domains in T cell development and function. Immunity (2001) 1.36
Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes. J Clin Invest (1997) 1.29
Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci U S A (1992) 1.28
Efficient liver-specific deletion of a floxed human angiotensinogen transgene by adenoviral delivery of Cre recombinase in vivo. J Biol Chem (1999) 1.28
Molecular structure and flanking nucleotide sequences of the natural chicken ovomucoid gene. Cell (1979) 1.27
Retinoic acid-mediated activation of the mouse renin enhancer. J Biol Chem (2000) 1.25
Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab (1996) 1.22
Role of proximal promoter elements in regulation of renin gene transcription. J Biol Chem (1996) 1.22
Elevated blood pressure in transgenic mice with brain-specific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoter. Circ Res (2001) 1.22
Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem (1994) 1.22
The ovalbumin gene: cloning of the natural gene. Proc Natl Acad Sci U S A (1978) 1.19
Androgen-dependent regulation of human angiotensinogen expression in KAP-hAGT transgenic mice. Am J Physiol Renal Physiol (2001) 1.19
The effects of deletions in the central helix of calmodulin on enzyme activation and peptide binding. J Biol Chem (1989) 1.16
The use of thoracic impedance for determining thoracic blood volume changes in man. Aviat Space Environ Med (1986) 1.15
Detection of early changes in androgen-induced mouse renal beta-glucuronidase messenger ribonucleic acid using cloned complementary deoxyribonucleic acid. Biochemistry (1983) 1.14
Gene transfer of endothelial nitric oxide synthase (eNOS) in eNOS-deficient mice. Am J Physiol (1999) 1.12
Spectinomycin resistance due to a mutation in an rRNA operon of Escherichia coli. J Bacteriol (1983) 1.11
Cloning of cDNA encoding the pre-beta subunit of mouse thyrotropin. Proc Natl Acad Sci U S A (1983) 1.11
The ovalbumin gene: organization, structure, transcription, and regulation. Recent Prog Horm Res (1979) 1.11
Identification of three human renin mRNA isoforms from alternative tissue-specific transcriptional initiation. Physiol Genomics (2000) 1.11
Genetic susceptibility to preeclampsia: roles of cytosineto-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation. Am J Obstet Gynecol (2001) 1.10
Highly regulated cell type-restricted expression of human renin in mice containing 140- or 160-kilobase pair P1 phage artificial chromosome transgenes. J Biol Chem (1999) 1.09
Identification of cis elements in the cardiac troponin T gene conferring specific expression in cardiac muscle of transgenic mice. Circ Res (2000) 1.08
Vesical dysfunction induced by the major tranquilizers. J Urol (1972) 1.07
Appropriate tissue- and cell-specific expression of a single copy human angiotensinogen transgene specifically targeted upstream of the HPRT locus by homologous recombination. J Biol Chem (2000) 1.05
Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta (2005) 1.05
Primary sequence of ovomucoid messenger RNA as determined from cloned complementary DNA. J Cell Biol (1980) 1.04
Munc18c regulates insulin-stimulated glut4 translocation to the transverse tubules in skeletal muscle. J Biol Chem (2000) 1.04
Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats. Am J Physiol Regul Integr Comp Physiol (2007) 1.04
AATF mediates an antiapoptotic effect of the unfolded protein response through transcriptional regulation of AKT1. Cell Death Differ (2009) 1.03
A case of giant prostatic hyperplasia. Urology (1993) 1.01
Transgenic mice expressing an intracellular fluorescent fusion of angiotensin II demonstrate renal thrombotic microangiopathy and elevated blood pressure. Am J Physiol Heart Circ Physiol (2010) 1.01
Distribution of angiotensin type 1a receptor-containing cells in the brains of bacterial artificial chromosome transgenic mice. Neuroscience (2012) 1.01
Enhanced expression of Ang-(1-7) during pregnancy. Braz J Med Biol Res (2004) 1.00
Testin secreted by Sertoli cells is associated with the cell surface, and its expression correlates with the disruption of Sertoli-germ cell junctions but not the inter-Sertoli tight junction. J Biol Chem (1998) 0.99
Transactivation of the human renin promoter by the cyclic AMP/protein kinase A pathway is mediated by both cAMP-responsive element binding protein-1 (CREB)-dependent and CREB-independent mechanisms in Calu-6 cells. J Biol Chem (1997) 0.99
The angiotensinogen gene is expressed in both astrocytes and neurons in murine central nervous system. Brain Res (1999) 0.98
NF-Y antagonizes renin enhancer function by blocking stimulatory transcription factors. Hypertension (2001) 0.97
Expression of murine renin genes during fetal development. Mol Endocrinol (1990) 0.97
Vectors for high-level expression of cDNAs controlled by tissue-specific promoters in transgenic mice. Biotechniques (2001) 0.96
Macrophage-specific expression of human lipoprotein lipase accelerates atherosclerosis in transgenic apolipoprotein e knockout mice but not in C57BL/6 mice. Arterioscler Thromb Vasc Biol (2001) 0.95
Identification and characterization of two androgen response regions in the human neutral endopeptidase gene. Mol Cell Endocrinol (2000) 0.95
Interactions of proteases and protease inhibitors in Sertoli-germ cell cocultures preceding the formation of specialized Sertoli-germ cell junctions in vitro. J Androl (1998) 0.94
Species-specific differences in positive and negative regulatory elements in the renin gene enhancer. Circ Res (1999) 0.94
Nucleotide sequence of kidney androgen-regulated protein mRNA and its cell-specific expression in Tfm/Y mice. Mol Endocrinol (1989) 0.94
Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase. J Thromb Haemost (2010) 0.93
Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen. Stroke (2000) 0.93
Differential regulation of gene expression during macrophage activation with a polyribonucleotide. The role of endogenously derived IFN. J Immunol (1988) 0.92
Changes in the expression of junctional and nonjunctional complex component genes when inter-sertoli tight junctions are formed in vitro. J Androl (2000) 0.92
Mouse kidney androgen-regulated protein messenger ribonucleic acid is expressed in the proximal convoluted tubules. Mol Endocrinol (1987) 0.92
Progesterone stimulates calcitonin gene expression in the uterus during implantation. Endocrinology (1994) 0.92
Conserved enhancer elements in human and mouse renin genes have different transcriptional effects in As4.1 cells. Circ Res (1997) 0.92
Allele-specific expression of the murine Ren-1 genes. J Biol Chem (1989) 0.91
Endogenous human renin expression and promoter activity in CALU-6, a pulmonary carcinoma cell line. Hypertension (1995) 0.91
Regulation of gene expression by androgens in murine kidney. Recent Prog Horm Res (1986) 0.90
Vascular biology in genetically altered mice : smaller vessels, bigger insight. Circ Res (2000) 0.89
Ontogeny of baroreflex control of renal sympathetic nerve activity and heart rate. Am J Physiol (1992) 0.89
Genetic evidence that lethality in angiotensinogen-deficient mice is due to loss of systemic but not renal angiotensinogen. J Biol Chem (2000) 0.89
Expression of the DBA/2J Ren-2 gene in the adrenal gland of transgenic mice. EMBO J (1989) 0.88
Rat testin is a newly identified component of the junctional complexes in various tissues whose mRNA is predominantly expressed in the testis and ovary. Biol Reprod (1995) 0.88
Genetic regulation of androgen-induced accumulation of mouse renal beta-glucuronidase messenger ribonucleic acid. Endocrinology (1986) 0.88
Contrast agent-enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy. Magn Reson Med (2000) 0.88
Effects of luteinizing hormone (LH) and androgen on steady state levels of messenger ribonucleic acid for LH receptors, androgen receptors, and steroidogenic enzymes in rat Leydig cell progenitors in vivo. Endocrinology (1995) 0.88
JG cell expression and partial regulation of a human renin genomic transgene driven by a minimal renin promoter. Am J Physiol (1999) 0.87
Biosynthesis of renin in mouse kidney tumor As4.1 cells. Eur J Biochem (1997) 0.87
Cloning and uterus/oviduct-specific expression of a novel estrogen-regulated gene (ERG1) J Biol Chem (1999) 0.86